Nadthakarn Boland

Title: Nadthakarn Boland: Innovator in Antibody Development

Introduction

Nadthakarn Boland is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for medical treatments and diagnostics.

Latest Patents

Nadthakarn Boland holds a patent for an "Anti-PCSK9 antibody and use thereof." This invention provides an antibody that specifically binds to proprotein convertase subtilisin/kexin type 9 (PCSK9). The patent also includes an antigen-binding fragment of the antibody, a composition comprising the antibody or the fragment, and a nucleic acid that encodes the antibody or the fragment. Additionally, it describes a host cell containing the nucleic acid and applications of the antibody and fragment in treatment and diagnosis. He has 1 patent to his name.

Career Highlights

Nadthakarn Boland is associated with Innovent Biologics (Suzhou) Co., Ltd., where he continues to advance his research and development efforts. His work at Innovent Biologics has positioned him as a key player in the biotechnology sector, contributing to the company's mission of providing innovative therapies.

Collaborations

Some of his notable coworkers include Andy Tsun and Eric Krauland. Their collaboration enhances the research environment and fosters innovation within the company.

Conclusion

Nadthakarn Boland's contributions to antibody development exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.